US States Sue FDA Over Abortion Pill Access, Claiming 'Arbitrary' Approval Process
In a move that could have far-reaching implications for reproductive rights in the US, Texas and Florida have filed a joint lawsuit against the Food and Drug Administration (FDA), seeking to overturn decades of policy governing access to mifepristone, a commonly used abortion pill.
The states claim that the FDA's original approval of mifepristone in 2000 was based on an "arbitrary, capricious, abuse of discretion, not in accordance with law," and that subsequent policies expanding access to the medication were similarly flawed. The lawsuit challenges the agency's decision to authorize a new generic version of the drug, as well as its relaxed prescribing rules and mail delivery policies.
Proponents of abortion rights argue that the FDA's actions are grounded in science and have been consistently shown to be safe and effective through over 100 studies conducted around the world. However, critics say the lawsuit is an attempt by conservative states to restrict access to abortion.
"This lawsuit has nothing to do with the safety of this medication and everything to do with making it harder for people to get an abortion," said Julia Kaye, senior staff attorney with the ACLU's Reproductive Freedom Project. "Politicians in Texas and Florida are asking for a nationwide ban on a safe and effective medication that millions of Americans have used since the FDA first approved it 25 years ago."
The move is part of a broader attempt by conservative states to chip away at access to abortion, with Missouri, Kansas, and Idaho also filing lawsuits challenging the FDA's approval of mifepristone.
A delay in the FDA's review of mifepristone's safety has been announced, which some say may be intended to minimize its impact ahead of next year's midterm elections. The decision has sparked widespread criticism from abortion rights groups and supporters of access to reproductive healthcare.
In a move that could have far-reaching implications for reproductive rights in the US, Texas and Florida have filed a joint lawsuit against the Food and Drug Administration (FDA), seeking to overturn decades of policy governing access to mifepristone, a commonly used abortion pill.
The states claim that the FDA's original approval of mifepristone in 2000 was based on an "arbitrary, capricious, abuse of discretion, not in accordance with law," and that subsequent policies expanding access to the medication were similarly flawed. The lawsuit challenges the agency's decision to authorize a new generic version of the drug, as well as its relaxed prescribing rules and mail delivery policies.
Proponents of abortion rights argue that the FDA's actions are grounded in science and have been consistently shown to be safe and effective through over 100 studies conducted around the world. However, critics say the lawsuit is an attempt by conservative states to restrict access to abortion.
"This lawsuit has nothing to do with the safety of this medication and everything to do with making it harder for people to get an abortion," said Julia Kaye, senior staff attorney with the ACLU's Reproductive Freedom Project. "Politicians in Texas and Florida are asking for a nationwide ban on a safe and effective medication that millions of Americans have used since the FDA first approved it 25 years ago."
The move is part of a broader attempt by conservative states to chip away at access to abortion, with Missouri, Kansas, and Idaho also filing lawsuits challenging the FDA's approval of mifepristone.
A delay in the FDA's review of mifepristone's safety has been announced, which some say may be intended to minimize its impact ahead of next year's midterm elections. The decision has sparked widespread criticism from abortion rights groups and supporters of access to reproductive healthcare.